According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Protalix BioTherapeutics, Inc. (NYSE: PLX), a biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins, recently disclosed its ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Protalix ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

"We are pleased to report that all eight cohorts of our phase I first-in-human study of PRX-115, our recombinant uricase candidate being developed for the treatment of uncontrolled gout, are now ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...